157 related articles for article (PubMed ID: 1328060)
41. A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae.
Triccas JA; Roche PW; Winter N; Feng CG; Butlin CR; Britton WJ
Infect Immun; 1996 Dec; 64(12):5171-7. PubMed ID: 8945562
[TBL] [Abstract][Full Text] [Related]
42. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
Desai SD; Birdi TJ; Antia NH
Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
[TBL] [Abstract][Full Text] [Related]
43.
Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
Front Immunol; 2018; 9():2920. PubMed ID: 30631322
[TBL] [Abstract][Full Text] [Related]
44. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic and functional characterization of human suppressor T-cell clones: II. Activation by Mycobacterium leprae presented by HLA-DR molecules to alpha beta T-cell receptors.
Li SG; Elferink DG; de Vries RR
Hum Immunol; 1990 May; 28(1):11-26. PubMed ID: 1692823
[TBL] [Abstract][Full Text] [Related]
46. Preliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patients.
Rada EM; Santaella C; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):189-94. PubMed ID: 1522361
[TBL] [Abstract][Full Text] [Related]
47. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae.
Mustafa AS; Lundin KE; Oftung F
Infect Immun; 1993 Dec; 61(12):5294-301. PubMed ID: 8225603
[TBL] [Abstract][Full Text] [Related]
48. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy.
Agis F; Schlich P; Cartel JL; Guidi C; Bach MA
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):527-35. PubMed ID: 3065419
[TBL] [Abstract][Full Text] [Related]
49. Human T cell responses to peptides of the Mycobacterium leprae 45-kD serine-rich antigen.
Brahmbhatt S; Hussain R; Zafar S; Dawood G; Ottenhoff TH; Drijfhout JW; Bothamley G; Smith S; Lopez FV; Dockrell HM
Clin Exp Immunol; 2002 Apr; 128(1):140-8. PubMed ID: 11982601
[TBL] [Abstract][Full Text] [Related]
50. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
[TBL] [Abstract][Full Text] [Related]
51. Mapping of V beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis.
Yanagisawa S; Koike M; Kariyone A; Nagai S; Takatsu K
Int Immunol; 1997 Feb; 9(2):227-37. PubMed ID: 9040005
[TBL] [Abstract][Full Text] [Related]
52. Genetic control of immunopathology induced by Mycobacterium leprae.
de Vries RR
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):12-6. PubMed ID: 1904200
[TBL] [Abstract][Full Text] [Related]
53. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
54. Definition of a human suppressor T-cell epitope.
Mutis T; Cornelisse YE; Datema G; van den Elsen PJ; Ottenhoff TH; de Vries RR
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9456-60. PubMed ID: 7524076
[TBL] [Abstract][Full Text] [Related]
55. Immunity to leprosy. IV. Murine T-cell proliferative responses to mycobacteria.
Douglas-Jones AG; Wade SM; Vaughan RH; Watson JD
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):367-79. PubMed ID: 3528344
[TBL] [Abstract][Full Text] [Related]
56. Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli.
Mustafa AS; Gill HK; Nerland A; Britton WJ; Mehra V; Bloom BR; Young RA; Godal T
Nature; 1986 Jan 2-8; 319(6048):63-6. PubMed ID: 3510397
[TBL] [Abstract][Full Text] [Related]
57. T-cell stimulation with purified mycobacterial antigens in patients and healthy subjects infected with Mycobacterium leprae: secreted antigen 85 is another immunodominant antigen.
Launois P; Niang MN; Sarthou JL; Rivier F; Drowart A; Van Vooren JP; Millan J; Huygen K
Scand J Immunol; 1993 Aug; 38(2):167-76. PubMed ID: 8346416
[TBL] [Abstract][Full Text] [Related]
58. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
[TBL] [Abstract][Full Text] [Related]
59. CD4+ T-cell responses to recombinant hsp65 and hsp18 of M. leprae and their trypsin-digested fragments in leprosy: diversity in HLA-DR restriction.
Mitra DK; Mehra NK; Maiti TK; Banerjee A; Taneja V; Rajalingam R; Ahuja RK; Bhattacharya BC
Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):518-28. PubMed ID: 8642214
[TBL] [Abstract][Full Text] [Related]
60. HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells.
Haanen JB; Ottenhoff TH; Voordouw A; Elferink BG; Klatser PR; Spits H; De Vries RR
Scand J Immunol; 1986 Jan; 23(1):101-8. PubMed ID: 2422737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
